{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:11:36Z","timestamp":1792509096688,"version":"4.5.0"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Membranous nephropathy (MN) is a common cause of proteinuria and nephrotic syndrome all over the world. It can be subdivided into primary and secondary forms. Primary form is an autoimmune disease clinically characterized by nephrotic syndrome and slow progression. It accounts for ~70% cases of MN. In the remaining cases MN may be secondary to well-defined causes, including infections, drugs, cancer, or autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), urticarial vasculitis, sarcoidosis, thyroiditis, Sjogren syndrome, systemic sclerosis, or ankylosing spondylitis. The clinical presentation is similar in primary and secondary MN. However, the outcome may be different, being often related to that of the original disease in secondary MN. Also, the treatment may be different, being targeted to the etiologic cause in secondary MN. Thus, the differential diagnosis between primary and secondary MN is critical and should be based not only on history and clinical features of the patient but also on immunofluorescence and electron microscopy analysis of renal biopsy as well as on the research of circulating antibodies. The identification of the pathologic events underlying a secondary MN is of paramount importance, since the eradication of the etiologic factors may be followed by remission or definitive cure of MN. In this review we report the main diseases and drugs responsible of secondary MN, the outcome and the pathogenesis of renal disease in different settings and the possible treatments.<\/jats:p>","DOI":"10.3389\/fmed.2020.611317","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T08:30:39Z","timestamp":1606984239000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":76,"title":["Secondary Membranous Nephropathy. A Narrative Review"],"prefix":"10.3389","volume":"7","author":[{"given":"Gabriella","family":"Moroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ponticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/MNH.0000000000000459","article-title":"Unmet challenges in membranous nephropathy","volume":"28","author":"Salant","year":"2019","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"B4","doi-asserted-by":"publisher","first-page":"c41","DOI":"10.1159\/000324652","article-title":"Treatment of hepatitis b virus-associated nephropathy","volume":"119","author":"Elewa","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1038\/ki.1996.519","article-title":"Detection of hepatitis B virus DNA and RNA in kidneys of HBV-related glomerulonephritis","volume":"50","author":"Lai","year":"1996","journal-title":"Kidney Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.2215\/CJN.09180816","article-title":"Viral-associated GN. Hepatitis B and other viral infections","volume":"12","author":"Kupin","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1159\/000431331","article-title":"Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy","volume":"41","author":"Xie","year":"2015","journal-title":"Am J Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000185916","article-title":"Hepatitis B virus-associated membranous nephropathy: clinical features, immunological profiles and outcome","volume":"55","author":"Lin","year":"1990","journal-title":"Nephron"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1056\/NEJM199105233242103","article-title":"Membranous nephropathy related to hepatitis B virus in adults","volume":"324","author":"Lai","year":"1991","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3949\/ccjm.74.5.353","article-title":"Viral infections and the kidney: HIV, hepatitis B, and hepatitis C. cleve","volume":"74","author":"Appel","year":"2007","journal-title":"Clin J Med."},{"key":"B11","first-page":"71","article-title":"Detection of hepatitis C virus core protein in the glomeruli of patients with membranous glomerulonephritis","volume":"45","author":"Okada","year":"1996","journal-title":"Clin Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"22299","DOI":"10.18632\/oncotarget.15397","article-title":"Membranous nephropathy associated with hepatitis C virus infection treated with corticosteroids and ledipasvir-sofosbuvir: a case report and review of literature","volume":"8","author":"Weng","year":"2017","journal-title":"Oncotarget."},{"key":"B13","doi-asserted-by":"publisher","first-page":"41764","DOI":"10.18632\/oncotarget.16986","article-title":"The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents","volume":"8","author":"Roccatello","year":"2017","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/jvh.12402","article-title":"Hepatitis B reactivation in HBsAg-negative\/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis","volume":"22","author":"Mozessohn","year":"2015","journal-title":"J Viral Hepat."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0160437","DOI":"10.1371\/journal.pone.0160437","article-title":"A meta-analysis of antiviral therapy for hepatitis B virus-associated membranous nephropathy","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS ONE"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/j.1523-1755.2005.00591.x","article-title":"Lamivudine in hepatitis B-associated membranous nephropathy","volume":"68","author":"Tang","year":"2005","journal-title":"Kidney Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.cca.2016.01.020","article-title":"The combination of tacrolimus and entecavir improves the remission of HBV-associated glomerulonephritis without enhancing viral replication","volume":"8","author":"Wang","year":"2016","journal-title":"Am J Transl Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.rdc.2018.06.006","article-title":"Autoimmune kidney diseases associated with viral infections","volume":"44","author":"Long","year":"2018","journal-title":"Rheum Dis Clin North Am."},{"key":"B19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/0377-4929.97893","article-title":"Can influenza H1N1 vaccination lead to the membranous glomerulonephriris?","volume":"55","author":"Kutlucan","year":"2012","journal-title":"Indian J Pathol Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/ncpneph0166","article-title":"Viral nephropathy","volume":"2","author":"Lai","year":"2006","journal-title":"Nat Clin Pract Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S2222-1808(13)60018-3","article-title":"Schistosomiasis-associated kidney disease: a review","volume":"3","author":"da Silva","year":"2013","journal-title":"Asian Pac J Trop Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1590\/S0036-46651999000500001","article-title":"Schistosoma mansoni associated glomerulopathy","volume":"41","author":"Brito","year":"1999","journal-title":"Rev Inst Med Trop S\u00e1o P\u00e1ulo."},{"key":"B23","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.kint.2015.12.015","article-title":"Schistosoma mansoni and membranous nephropathy","volume":"89","author":"Neves","year":"2016","journal-title":"Kidney Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.4269\/ajtmh.1977.26.717","article-title":"Elution of renal antischistosome antibodies in human schistosomiasis mansoni","volume":"26","author":"Moriearty","year":"1977","journal-title":"Am J Trop Med Hyg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ndt\/17.1.4","article-title":"Human schistosoma mansoni-associated glomerulopathy in Brazil","volume":"17","author":"Nussenzveig","year":"2002","journal-title":"Nephrol Dial Transplant."},{"key":"B26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.kint.2019.05.024","article-title":"The immunohistological profile of membranous nephropathy associated with chronic schistosoma mansoni infection reveals a glomerulopathy with primary features","volume":"96","author":"Ara\u00fajo","year":"2019","journal-title":"Kidney Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4103\/ijn.IJN_7_18","article-title":"Primary membranous glomerulonephritis-associated with schistosomal nephropathy","volume":"29","author":"Ibrahim","year":"2019","journal-title":"Indian J Nephrol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1128\/CMR.13.1.55","article-title":"Glomerulopathy associated with parasitic infections","volume":"13","author":"van Velthuysen","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1053\/snep.2003.50001","article-title":"Glomerular disease in the tropics","volume":"23","author":"Seedat","year":"2003","journal-title":"Semin Nephrol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7812\/TPP\/17-062","article-title":"Secondary syphilis associated with membranous nephropathy and acute hepatitis in a patient with HIV: a case report","volume":"22","author":"Zhang","year":"2018","journal-title":"Perm J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1081\/JDI-200065304","article-title":"Secondary membranous nephropathy\u2014one center experience","volume":"27","author":"Rihova","year":"2005","journal-title":"Ren Fail."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.2215\/CJN.01910215","article-title":"Drug-induced glomerular disease: immune-mediated injury","volume":"10","author":"Hogan","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1517\/14740338.5.1.95","article-title":"Drug-induced glomerulopathies","volume":"5","author":"Izzedine","year":"2006","journal-title":"Expert Opin Drug Saf."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/ndt\/gfh832","article-title":"Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis","volume":"20","author":"Stokes","year":"2005","journal-title":"Nephrol Dial Transplant."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13730-019-00414-3","article-title":"A case of denosumab-associated membranous nephropathy in a patient with rheumatoid arthritis","volume":"9","author":"Kimoto","year":"2020","journal-title":"CEN Case Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0002-9343(86)90722-9","article-title":"Adverse effects profile of sulfhydryl compounds in man","volume":"80","author":"Jaffe","year":"1986","journal-title":"Am J Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1007\/s00467-009-1245-3","article-title":"Lithium-induced membranous glomerulonephropathy in a pediatric patient","volume":"24","author":"Kala","year":"2009","journal-title":"Pediatr Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2215\/CJN.01010115","article-title":"Drug-induced glomerular disease: attention required!","volume":"10","author":"Rhadakrishnan","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2215\/CJN.07571009","article-title":"Mercury-induced membranous nephropathy: clinical and pathological features","volume":"5","author":"Li","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5414\/CNP59137","article-title":"Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib","volume":"59","author":"Markowitz","year":"2003","journal-title":"Clin Nephrol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/jama.1996.03540060042033","article-title":"Reversiblemembranousnephropathy associated with the use of nonsteroidal anti-inflammatory drugs","volume":"276","author":"Radford","year":"1996","journal-title":"JAMA."},{"key":"B42","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/oxfordjournals.ndt.a091897","article-title":"Reversible membranous nephritis associated with diclofenac","volume":"4","author":"Campistol","year":"2011","journal-title":"Nephrol Dial Transplant."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1056\/NEJMoa1013792","article-title":"Early-childhood membranous nephropathy due to cationic bovine serum albumin","volume":"364","author":"Debiec","year":"2011","journal-title":"N Engl J Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1056\/NEJMe1103049","article-title":"Milk and membranous nepropathy","volume":"364","author":"Fogo","year":"2011","journal-title":"N Engl J Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ki.1986.209","article-title":"Neoplasia and glomerular injury","volume":"30","author":"Alpers","year":"1986","journal-title":"Kidney Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1046\/j.1523-1755.2003.00771.x","article-title":"Glomerulonephritis and malignancy: a population-based analysis","volume":"63","author":"Birkeland","year":"2003","journal-title":"Kidney Int."},{"key":"B47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12882-018-0828-2","article-title":"Quantification of cancer risk in glomerulonephritis","volume":"19","author":"Heaf","year":"2018","journal-title":"BMC Nephrol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/sj.ki.5001790","article-title":"GN-PROGRESS study group membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association","volume":"70","author":"Lefaucheur","year":"2006","journal-title":"Kidney Int"},{"key":"B49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.ajkd.2007.06.003","article-title":"Long-term risk of cancer in membranous nephropathy patients","volume":"50","author":"Bj\u00f8rneklett","year":"2007","journal-title":"Am J Kidney Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000364782","article-title":"Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies","volume":"40","author":"Leeaphorn","year":"2014","journal-title":"Am J Nephrol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"886","DOI":"10.2215\/CJN.09000819","article-title":"Screening for cancer in patients with glomerular diseases","volume":"15","author":"Plaisier","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/ndt\/gfg616","article-title":"Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy","volume":"19","author":"Ohtani","year":"2004","journal-title":"Nephrol Dial Transplant."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/ndt\/gfr534","article-title":"Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy","volume":"27","author":"Qu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B54","doi-asserted-by":"publisher","first-page":"S0085","DOI":"10.1016\/j.kint.2020.07.039","article-title":"NELL1 is a target antigen in malignancy associated membranous nephropathy","volume":"20","author":"Caza","year":"2020","journal-title":"Kidney Int"},{"key":"B55","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1046\/j.1523-1755.1999.00548.x","article-title":"Paraneoplastic glomerulopathies: new insights into an old entity","volume":"56","author":"Ronco","year":"1999","journal-title":"Kidney Int."},{"key":"B56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.semnephrol.2010.09.011","article-title":"Membranous nephropathy and malignancy","volume":"30","author":"Beck","year":"2010","journal-title":"Semin Nephrol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/ki.2012.209","article-title":"Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy","volume":"82","author":"Hoxha","year":"2012","journal-title":"Kidney Int."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1053\/j.ajkd.2013.07.019","article-title":"Anti-phospholipase A2 receptor and malignancy in membranous nephropathy","volume":"62","author":"Timmermans","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Antiphospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.08.003","article-title":"Paraneoplastic glomerular diseases and malignancies","volume":"70","author":"Bacchetta","year":"2009","journal-title":"Crit Rev Oncol Hematol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2215\/CJN.04160413","article-title":"Glomerular diseases: membranous nephropathy\u2013a modern view","volume":"9","author":"Ponticelli","year":"2014","journal-title":"Clin J Am Soc Nephrol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1053\/j.ackd.2013.08.003","article-title":"Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation","volume":"21","author":"Jhaveri","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0270-9295(03)00055-X","article-title":"Therapy of membranous nephropathy associated with malignancy and secondary causes","volume":"23","author":"Jefferson","year":"2003","journal-title":"Semin Nephrol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1681\/ASN.2018050488","article-title":"Nephrotoxicity of cancer immunotherapies: past, present and future","volume":"29","author":"Perazella","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"90","DOI":"10.6002\/ect.mesot2016.O70","article-title":"Nephrotic syndrome after hematopoietic stem cell transplant: outcomes in Iran","volume":"15","author":"Saddadi","year":"2017","journal-title":"Exp Clin Transplant."},{"key":"B66","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2215\/CJN.00380705","article-title":"Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?","volume":"1","author":"Brukamp","year":"2006","journal-title":"Clin J Am Soc Nephrol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12882-018-0855-z","article-title":"Membranous nephropathy succeeding autologous hematopoietic stem cell transplant: a case report","volume":"19","author":"Mrabet","year":"2018","journal-title":"BMC Nephrology."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/ndt\/gfl795","article-title":"Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects","volume":"22","author":"Terrier","year":"2007","journal-title":"Nephrol Dial Transplant."},{"key":"B69","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bcmd.2010.12.003","article-title":"Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesis","volume":"46","author":"Luo","year":"2011","journal-title":"Blood Cells Mol Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1182\/blood-2008-10-161638","article-title":"The role of B cells in the pathogenesis of graft-versus-host disease","volume":"114","author":"Shimabukuro-Vornhagen","year":"2009","journal-title":"Blood."},{"key":"B71","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.exphem.2005.12.011","article-title":"The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery","volume":"34","author":"Patriarca","year":"2006","journal-title":"Exp Hematol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/MAJ.0b013e318267b5cd","article-title":"Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy","volume":"346","author":"Huang","year":"2013","journal-title":"Am J Med Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/ckj\/sfv036","article-title":"Membranous nephropathy in autologous hematopoietic stem cell transplant: autologous graft-versus-host disease or autoimmunity induction?","volume":"8","author":"Abudayyeh","year":"2015","journal-title":"Clin Kidney J."},{"key":"B74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.krcp.2012.09.008","article-title":"A case of membranous nephropathy as a manifestation of graft-versus-host disease","volume":"32","author":"Han","year":"2013","journal-title":"Kidney Res Clin Pract"},{"key":"B75","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/bmt.2011.4","article-title":"A case of membranous nephropathy associated with chronic GVHD successfully treated with rituximab","volume":"47","author":"Iguchi","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"B76","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/1871525711311010011","article-title":"The management of membranous glomerulopathy in allogeneic stem cells transplantation: updated literature","volume":"11","author":"Niscola","year":"2013","journal-title":"Cardiovasc Hematol Agents Med Chem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nrneph.2009.14","article-title":"Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma","volume":"5","author":"Mok","year":"2009","journal-title":"Nat Rev Nephrol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"936","DOI":"10.2169\/internalmedicine.41.936","article-title":"Glomerular and Serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy","volume":"41","author":"Kuroki","year":"2002","journal-title":"Intern Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1681\/ASN.2018080852","article-title":"Exostosin 1\/exostosin 2\u2013associated membranous nephropathy","volume":"30","author":"Sethi","year":"2019","journal-title":"J Am Soc Nephrol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ncprheum0191","article-title":"Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus","volume":"2","author":"Cook","year":"2006","journal-title":"Nat Clin Pract Rheumatol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J Am Soc Nephrol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3899\/jrheum.181232","article-title":"Neutrophil extracellular traps (NETs) profiles in patients with incident SLE and lupus nephritis","volume":"47","author":"Bruschi","year":"2020","journal-title":"J Rheumatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of human systemic lupus erythematosus: a cellular perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1191\/0961203305lu2062oa","article-title":"Membranous lupus nephritis","volume":"14","author":"Austin","year":"2005","journal-title":"Lupus."},{"key":"B86","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1681\/ASN.V72299","article-title":"Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus Nephritis Collaborative Study Group","volume":"7","author":"Sloan","year":"1996","journal-title":"J Am Soc Nephrol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1053\/j.ajkd.2003.10.029","article-title":"Treatment of pure membranous lupus nephropathy with prednisone and azathioprine: an open- label trial","volume":"43","author":"Mok","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/ndt\/17.10.1771","article-title":"Factors affecting outcome and prognosis in membranous lupus nephropathy","volume":"17","author":"Mercadal","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B89","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.semarthrit.2011.08.002","article-title":"Membranous nephropathy in systemic lupus erythematosus: long-term outcome and prognostic factors of 103 patients","volume":"41","author":"Moroni","year":"2012","journal-title":"Semin Arthritis Rheum."},{"key":"B90","doi-asserted-by":"publisher","first-page":"keaa103","DOI":"10.1093\/rheumatology\/keaa103","article-title":"Outcomes of membranous and proliferative lupus nephritis - analysis of a single-centre cohort with more than 30 years of follow-up","volume":"2020","author":"Farinha","year":"2020","journal-title":"Rheumatology."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/ki.1996.528","article-title":"\u201cNephritic flares\u201d are predictors of bad long-term renal outcome in lupus nephritis","volume":"50","author":"Moroni","year":"1996","journal-title":"Kidney Int"},{"key":"B92","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1191\/096120398678920776","article-title":"Flares in lupus nephritis: incidence, impact on renal survival and management","volume":"7","author":"Ponticelli","year":"1998","journal-title":"Lupus."},{"key":"B93","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaut.2016.06.006","article-title":"Lupus nephritis: when and how often to biopsy and what does it mean?","volume":"74","author":"Moroni","year":"2016","journal-title":"J Autoimmun."},{"key":"B94","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.ackd.2019.08.015","article-title":"The kidney biopsy in systemic lupus erythematosus: a view of the past and a vision of the future","volume":"26","author":"Ayoub","year":"2019","journal-title":"Adv Chronic Kidney Dis."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e7099","DOI":"10.1097\/MD.0000000000007099","article-title":"The value of repeat biopsy in lupus nephritis flares","volume":"96","author":"Narv\u00e1ez","year":"2017","journal-title":"Medicine"},{"key":"B96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat Rev Nephrol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2174\/1389201020666190102145305","article-title":"Hyperglycemia and diabetes induced by glucocorticoids in nondiabetic and diabetic patients: revision of literature and personal considerations","volume":"19","author":"Ceccarelli","year":"2018","journal-title":"Curr Pharm Biotec."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1681\/ASN.2006111300","article-title":"Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum","volume":"18","author":"Glassock","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0270-9295(03)00056-1","article-title":"Therapy of membranous nephropathy in systemic lupus erythematosus","volume":"23","author":"Balow","year":"2003","journal-title":"Semin Nephrol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1053\/j.ajkd.2016.07.026","article-title":"Membranous lupus nephritis: the same, but different","volume":"68","author":"Ward","year":"2016","journal-title":"Am J Kidney Dis."},{"key":"B101","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 Update of the joint European league against rheumatism and European renal association-European dialysis and transplant association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B102","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1681\/ASN.2008060665","article-title":"Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy","volume":"20","author":"Austin","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ki.2009.412","article-title":"Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis","volume":"77","author":"Radhakrishnan","year":"2010","journal-title":"Kidney Int"},{"key":"B105","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/annrheumdis-2014-206456","article-title":"Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up","volume":"75","author":"Mok","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B106","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1053\/ajkd.1998.v31.pm9531186","article-title":"Treatment of membranous lupus nephritis","volume":"31","author":"Moroni","year":"1998","journal-title":"Am J Kidney Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1136\/annrheumdis-2012-202844","article-title":"Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate but no oral steroids","volume":"72","author":"Condon","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/ndt\/gfs285","article-title":"Beyond the LUNAR trial. efficacy of rituximab in refractory lupus nephritis","volume":"28","author":"Weidenbusch","year":"2013","journal-title":"Nephrol Dial Transplant."},{"key":"B109","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3109\/s101650200025","article-title":"Renal involvement in rheumatoid arthritis: analysis of renal biopsy specimens from 100 patients","volume":"12","author":"Makino","year":"2002","journal-title":"Mod Rheumatol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/RHU.0000000000000302","article-title":"Analysis of 65 renal biopsies from patients with rheumatoid arthritis (1976-2015): change in treatment strategies decreased frequency and modified histopathological findings","volume":"21","author":"Vinicki","year":"2015","journal-title":"J Clin Rheumatol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/1319-2442.198118","article-title":"Evaluation of renal lesions and clinicopathologic correlation in rheumatoid arthritis","volume":"28","author":"Muthukumar","year":"2017","journal-title":"Saudi J Kidney Dis Transpl."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3389\/fimmu.2019.01990","article-title":"Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders","volume":"10","author":"Kaegi","year":"2019","journal-title":"Front Immunol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/03009740801910338","article-title":"Membranous nephropathy associated with rheumatoid arthritis may respond to rituximab","volume":"37","author":"Pixley","year":"2008","journal-title":"Scand J Rheumatol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/anr.1780320910","article-title":"Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome","volume":"32","author":"Wisnieski","year":"1989","journal-title":"Arthritis Rheum."},{"key":"B115","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11926-009-0060-y","article-title":"Hypocomplementemic urticarial vasculitis syndrome","volume":"11","author":"Jara","year":"2009","journal-title":"Curr Rheumatol Rep."},{"key":"B116","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00063-001-1040-9","article-title":"Kidney involvement in hypocomplementemic urticaria-vasculitis syndrome\u2013a simulated systemic lupus erythematosis","volume":"96","author":"Brass","year":"2001","journal-title":"Med Klin."},{"key":"B117","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.anai.2017.01.017","article-title":"Urticarial vasculitis and associated disorders","volume":"118","author":"Hamad","year":"2017","journal-title":"Ann Allergy Asthma Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000187758","article-title":"Membranous nephropathy associated with hypocomplementemic urticarial vasculitis: report of two cases and a review of the literature","volume":"66","author":"Kobayashi","year":"1994","journal-title":"Nephron."},{"key":"B119","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.3346\/jkms.2017.32.12.2064","article-title":"Hypocomplementemic urticarial vasculitis syndrome with membranous nephropathy: case report","volume":"32","author":"Jung","year":"2017","journal-title":"J Korean Med Sci."},{"key":"B120","doi-asserted-by":"publisher","first-page":"E2131","DOI":"10.3390\/jcm9072131","article-title":"Kidney involvement in hypocomplementemic urticarial vasculitis syndrome-a case-based review","volume":"9","author":"Ion","year":"2010","journal-title":"J Clin Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jaci.2018.09.007","article-title":"Treatment of urticarial vasculitis: a systematic review","volume":"143","author":"Kolkhir","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40620-016-0279-4","article-title":"IgG4.related nephropathy","volume":"29","author":"Quattrocchio","year":"2016","journal-title":"J Nephol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"139409","DOI":"10.1155\/2012\/139409","article-title":"IgG4-related disease is not associated with antibody to the phospholipase A2 receptor","volume":"2012","author":"Khosroshahi","year":"2012","journal-title":"Int J Rheumatol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5527\/wjn.v7.i1.29","article-title":"Immunoglobulin G4-related kidney diseases: an updated review","volume":"7","author":"Salvadori","year":"2018","journal-title":"World J Nephrol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s10067-015-2870-9","article-title":"Childhood sarcoidosis: louisiana experience","volume":"35","author":"Gedalia","year":"2016","journal-title":"Clin Rheumatol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1750-1172-8-65","article-title":"Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study","volume":"8","author":"Stehl\u00e9","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"B127","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2169\/internalmedicine.38.882","article-title":"Sarcoidosis with membranous nephropathy and granulomatous interstitial nephritis","volume":"38","author":"Toda","year":"1999","journal-title":"Intern Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pneumo.2014.07.004","article-title":"Systemic sarcoidosis and membranous glomerulonephritis","volume":"70","author":"Aydi","year":"2014","journal-title":"Rev Pneumol Clin."},{"key":"B129","first-page":"390","article-title":"Membranous nephropathy associated with sarcoidosis: a primary or secondary glomerulopathy?","volume":"16","author":"Zilberman","year":"2014","journal-title":"Isr Med Assoc J."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/ndt\/gfv080","article-title":"Phospholipase A2 receptor and sarcoidosis-associated membranous nephropathy","volume":"30","author":"Stehl\u00e9","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B131","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fendo.2017.00119","article-title":"Autoimmune thyroiditis and glomerulopathies","volume":"8","author":"Santoro","year":"2017","journal-title":"Front Endocrinol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e19106","DOI":"10.1097\/MD.0000000000019106","article-title":"Clinical observation and analysis of thyroid hormone levels in patients with idiopathic membranous nephropathy","volume":"99","author":"Huang","year":"2020","journal-title":"Medicine."},{"key":"B133","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00467-008-0973-0","article-title":"Membranous nephropathy associated with thyroid-peroxidase antigen","volume":"24","author":"Shima","year":"2009","journal-title":"Pediatr Nephrol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s13730-013-0093-y","article-title":"Membranous nephropathy secondary to Graves' disease with deposits of thyroid peroxidase in an adult","volume":"3","author":"Sasaki","year":"2014","journal-title":"CEN Case Rep."},{"key":"B135","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1097\/MD.0000000000000063","article-title":"Membranous nephropathy with crescents in a patient with Hashimoto's thyroiditis: a case report","volume":"93","author":"Thajudeen","year":"2014","journal-title":"Medicine."},{"key":"B136","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/nrneph.2015.174","article-title":"Renal involvement in primary Sj\u00f6gren syndrome","volume":"12","author":"Fran\u00e7ois","year":"2016","journal-title":"Nat Rev Nephrol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1093\/ndt\/16.12.2328","article-title":"Clinical and morphological features of kidney involvement in primary Sj\u00f6gren's syndrome","volume":"16","author":"Bossini","year":"2001","journal-title":"Nephrol Dial Transplant."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2215\/CJN.00980209","article-title":"Renal involvement in primary Sj\u00f6gren's syndrome: a clinicopathologic study","volume":"4","author":"Maripuri","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/1756-185X.13182","article-title":"Renal involvement in primary Sj\u00f6gren's syndrome: a retrospective study of 103 biopsy-proven cases from a single center in China","volume":"21","author":"Yang","year":"2018","journal-title":"Int J Rheum Dis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/ndt\/gfv042","article-title":"Kidney biopsy findings in primary Sj\u00f6gren syndrome","volume":"30","author":"Kidder","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/art.38100","article-title":"Clinically significant renal involvement in primary Sj\u00f6gren's syndrome: clinical presentation and outcome","volume":"65","author":"Goules","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B142","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000452298","article-title":"Sj\u00f6gren syndrome-related membranous glomerulonephritis progressing to membranoproliferative glomerulonephritis","volume":"6","author":"Yabuuchi","year":"2016","journal-title":"Case Rep Nephrol Dial"},{"key":"B143","first-page":"509","article-title":"Glomerulonephritis leading to end stage renal disease in a patient with primary Sj\u00f6gren syndrome","volume":"13","author":"Dabadghao","year":"1995","journal-title":"Clin Exp Rheum"},{"key":"B144","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/BOR.0b013e3283588dcf","article-title":"Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management","volume":"24","author":"Shanmugam","year":"2012","journal-title":"Curr Opin Rheumatol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1159\/000489740","article-title":"Prognostic factors of renal involvement in systemic sclerosis","volume":"43","author":"Rosato","year":"2018","journal-title":"Kidney Blood Press Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/IJGM.S221471","article-title":"Renal pathology and clinical associations in systemic sclerosis: a historical cohort study","volume":"12","author":"Tonsawan","year":"2019","journal-title":"Int J Gen Me"},{"key":"B147","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1159\/000169183","article-title":"D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. case report and review of the literature","volume":"17","author":"Karpinski","year":"1997","journal-title":"Am J Nephrol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/rheumatology\/ker171","article-title":"A severe systemic sclerosis developing in a patient of membranous nephropathy","volume":"50","author":"Sarkar","year":"2011","journal-title":"Rheumatology"},{"key":"B149","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/oxfordjournals.ndt.a027270","article-title":"Membranous nephritis in a patient with scleroderma: a case report","volume":"11","author":"Parry","year":"1996","journal-title":"Nephrol Dial Transplant."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B151","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/BF01451293","article-title":"Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports","volume":"17","author":"Strobel","year":"1998","journal-title":"Clin Rheumatol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10157-009-0217-z","article-title":"Membranous glomerulonephritis in a patient with ankylosing spondylitis: a rare association","volume":"13","author":"Gupta","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"e8201","DOI":"10.1097\/MD.0000000000008201","article-title":"Membranous nephropathy in a patient with ankylosing spondylitis: a case report","volume":"96","author":"Chen","year":"2017","journal-title":"Medicine"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.611317\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T03:20:21Z","timestamp":1669951221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.611317\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":153,"alternative-id":["10.3389\/fmed.2020.611317"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.611317","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]},"article-number":"611317"}}